APGE vs TMO · $2.34B cap vs P/E 24, rev $23.00B
Apogee Therapeutics, Inc. Common Stock (APGE) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
APGE does not have a complete income-statement cache yet.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
APGE currently screens at market cap $2.34B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the APGE and TMO stock pages for the full models.
Not investment advice.